Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

Phase 3 Unknown 480 enrolled Chinese Academy of Medical Sciences Hubei Provincial Center for Disease Control and Prevention · collab

Non-randomizedSingle-groupOpen-labelPrevention

Summary

To evaluate the immunogenicity and safety of the third dose SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in adults aged 18 years and above, who inoculated the third dose after 6 months since finished two doses schedule of CoronaVac or BBIBP-CorV.

Timeline

Start: 2022-02-18
Primary completion: 2022-10-30
Completion: 2022-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SARS-CoV-2 Vaccine, Inactivated (Vero Cell)	Vaccine	—	—

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

Summary

Timeline

Drugs

Indications